The high energy cyclotron market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to development of early nuclear research facilities, increasing demand for medical isotope production, growth of oncology treatment research, expansion of particle physics experiments, and adoption of conventional cyclotron systems in research institutions.
The high energy cyclotron market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising demand for advanced cancer treatment technologies, increasing investment in nuclear medicine and radiopharmaceuticals, growth of precision oncology applications, expansion of government-funded research infrastructure, and increasing adoption of high-energy accelerator systems in scientific research. Major trends in the forecast period include increasing adoption of high-energy particle accelerators in advanced cancer radiotherapy and oncology research, rising demand for compact and efficient cyclotron systems for medical isotope production, growing integration of precision beam control technologies for improved particle acceleration accuracy, expansion of research-focused cyclotron facilities in nuclear physics and material science studies, and increasing use of automated control systems to enhance operational safety and efficiency in accelerator systems.
The increasing global cancer incidence and prevalence are expected to drive the growth of the high energy cyclotron market in the coming years. Cancer incidence refers to the number of newly diagnosed cancer cases within a defined time period. The rise in global cancer incidence and prevalence is primarily attributed to population aging, as the likelihood of developing cancer increases significantly with age, leading to a higher overall number of cases as the elderly population grows worldwide. High-energy cyclotrons support oncology care by enabling large-scale production of medical isotopes and proton beams used in advanced cancer diagnostics and targeted radiation therapies. For instance, in September 2025, according to the National Library of Medicine, a US-based government agency, the global cancer burden is expected to rise by 60.7% between 2024 and 2050, increasing from 19 million to 30.5 million cases. Therefore, the rising global cancer incidence and prevalence are driving the growth of the high energy cyclotron market.
Major companies operating in the high energy cyclotron market are focusing on the development of advanced solutions, such as high-current multi-energy cyclotron systems, to improve radioisotope production efficiency, enhance beam intensity control, and meet the increasing demand for advanced medical imaging and targeted cancer therapies. Multi-energy cyclotron systems are particle accelerator systems engineered to generate and accelerate charged particles at multiple selectable energy levels, supporting applications such as radioisotope production, medical imaging, and cancer treatment. For instance, in January 2024, Ion Beam Applications S.A., a Belgium-based particle accelerator technology company, announced the commissioning of its Cyclone 70 high-energy cyclotron system at iThemba LABS. This 70 MeV cyclotron is designed for the production of next-generation medical isotopes and operates at a full beam power of 750 µA, enabling high-yield isotope generation for clinical and research applications. The system supports the production of key isotopes such as strontium-82 for cardiovascular diagnostics and germanium-68 for PET imaging, while offering improved reliability, scalability, and integration with modern radiopharmaceutical workflows.
In February 2025, Ion Beam Applications S.A., a Belgium-based provider of particle accelerator and proton therapy solutions, entered into a strategic partnership with Framatome to expand a cyclotron network across Europe and the United States. Through this partnership, Ion Beam Applications S.A. aims to develop and deploy an industrial-scale network of advanced alpha-beam cyclotrons to enable large-scale production of Astatine-211 for targeted alpha therapy, thereby broadening the application of high-energy cyclotron technology in nuclear medicine and strengthening global theranostic supply chains. Framatome is a France-based nuclear engineering company specializing in reactor design, fuel production, and nuclear services, with increasing involvement in medical isotope production infrastructure.
Major companies operating in the high energy cyclotron market are Hitachi Ltd., Siemens Healthineers AG (including Varian Medical Systems), GE HealthCare Technologies Inc., Thales Group, L3Harris Technologies, Sumitomo Heavy Industries Ltd., Ion Beam Applications SA (IBA), The Japan Steel Works Ltd. (JSW), TeamBest Global Companies (Best Cyclotron Systems), Mevion Medical Systems Inc., Avelion (ALCEN Group), Sichuan Longevous Beamtech Co. Ltd., Hefei CAS Ion Medical and Technical Devices Co. Ltd. (CIM), Danfysik A/S, Haiming Medical Technology, Advanced Cyclotron Systems Inc. (ACSI)
North America was the dominant region in the high energy cyclotron market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in high energy cyclotron report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high energy cyclotron market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The high energy cyclotron market consists of sales of medical cyclotron, proton therapy cyclotron, and heavy ion cyclotron. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The high energy cyclotron market research report is one of a series of new reports that provides high energy cyclotron market statistics, including high energy cyclotron industry global market size, regional shares, competitors with a high energy cyclotron market share, detailed high energy cyclotron market segments, market trends and opportunities, and any further data you may need to thrive in the high energy cyclotron industry. This high energy cyclotron market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The high energy cyclotron market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising demand for advanced cancer treatment technologies, increasing investment in nuclear medicine and radiopharmaceuticals, growth of precision oncology applications, expansion of government-funded research infrastructure, and increasing adoption of high-energy accelerator systems in scientific research. Major trends in the forecast period include increasing adoption of high-energy particle accelerators in advanced cancer radiotherapy and oncology research, rising demand for compact and efficient cyclotron systems for medical isotope production, growing integration of precision beam control technologies for improved particle acceleration accuracy, expansion of research-focused cyclotron facilities in nuclear physics and material science studies, and increasing use of automated control systems to enhance operational safety and efficiency in accelerator systems.
The increasing global cancer incidence and prevalence are expected to drive the growth of the high energy cyclotron market in the coming years. Cancer incidence refers to the number of newly diagnosed cancer cases within a defined time period. The rise in global cancer incidence and prevalence is primarily attributed to population aging, as the likelihood of developing cancer increases significantly with age, leading to a higher overall number of cases as the elderly population grows worldwide. High-energy cyclotrons support oncology care by enabling large-scale production of medical isotopes and proton beams used in advanced cancer diagnostics and targeted radiation therapies. For instance, in September 2025, according to the National Library of Medicine, a US-based government agency, the global cancer burden is expected to rise by 60.7% between 2024 and 2050, increasing from 19 million to 30.5 million cases. Therefore, the rising global cancer incidence and prevalence are driving the growth of the high energy cyclotron market.
Major companies operating in the high energy cyclotron market are focusing on the development of advanced solutions, such as high-current multi-energy cyclotron systems, to improve radioisotope production efficiency, enhance beam intensity control, and meet the increasing demand for advanced medical imaging and targeted cancer therapies. Multi-energy cyclotron systems are particle accelerator systems engineered to generate and accelerate charged particles at multiple selectable energy levels, supporting applications such as radioisotope production, medical imaging, and cancer treatment. For instance, in January 2024, Ion Beam Applications S.A., a Belgium-based particle accelerator technology company, announced the commissioning of its Cyclone 70 high-energy cyclotron system at iThemba LABS. This 70 MeV cyclotron is designed for the production of next-generation medical isotopes and operates at a full beam power of 750 µA, enabling high-yield isotope generation for clinical and research applications. The system supports the production of key isotopes such as strontium-82 for cardiovascular diagnostics and germanium-68 for PET imaging, while offering improved reliability, scalability, and integration with modern radiopharmaceutical workflows.
In February 2025, Ion Beam Applications S.A., a Belgium-based provider of particle accelerator and proton therapy solutions, entered into a strategic partnership with Framatome to expand a cyclotron network across Europe and the United States. Through this partnership, Ion Beam Applications S.A. aims to develop and deploy an industrial-scale network of advanced alpha-beam cyclotrons to enable large-scale production of Astatine-211 for targeted alpha therapy, thereby broadening the application of high-energy cyclotron technology in nuclear medicine and strengthening global theranostic supply chains. Framatome is a France-based nuclear engineering company specializing in reactor design, fuel production, and nuclear services, with increasing involvement in medical isotope production infrastructure.
Major companies operating in the high energy cyclotron market are Hitachi Ltd., Siemens Healthineers AG (including Varian Medical Systems), GE HealthCare Technologies Inc., Thales Group, L3Harris Technologies, Sumitomo Heavy Industries Ltd., Ion Beam Applications SA (IBA), The Japan Steel Works Ltd. (JSW), TeamBest Global Companies (Best Cyclotron Systems), Mevion Medical Systems Inc., Avelion (ALCEN Group), Sichuan Longevous Beamtech Co. Ltd., Hefei CAS Ion Medical and Technical Devices Co. Ltd. (CIM), Danfysik A/S, Haiming Medical Technology, Advanced Cyclotron Systems Inc. (ACSI)
North America was the dominant region in the high energy cyclotron market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in high energy cyclotron report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high energy cyclotron market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The high energy cyclotron market consists of sales of medical cyclotron, proton therapy cyclotron, and heavy ion cyclotron. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The high energy cyclotron market research report is one of a series of new reports that provides high energy cyclotron market statistics, including high energy cyclotron industry global market size, regional shares, competitors with a high energy cyclotron market share, detailed high energy cyclotron market segments, market trends and opportunities, and any further data you may need to thrive in the high energy cyclotron industry. This high energy cyclotron market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. High Energy Cyclotron Market Characteristics
3. High Energy Cyclotron Market Supply Chain Analysis
4. Global High Energy Cyclotron Market Trends And Strategies
5. High Energy Cyclotron Market Analysis Of End Use Industries
7. Global High Energy Cyclotron Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global High Energy Cyclotron Total Addressable Market (TAM) Analysis for the Market
9. High Energy Cyclotron Market Segmentation
10. High Energy Cyclotron Market Regional And Country Analysis
11. Asia-Pacific High Energy Cyclotron Market
12. China High Energy Cyclotron Market
13. India High Energy Cyclotron Market
14. Japan High Energy Cyclotron Market
15. Australia High Energy Cyclotron Market
16. Indonesia High Energy Cyclotron Market
17. South Korea High Energy Cyclotron Market
18. Taiwan High Energy Cyclotron Market
19. South East Asia High Energy Cyclotron Market
20. Western Europe High Energy Cyclotron Market
21. UK High Energy Cyclotron Market
22. Germany High Energy Cyclotron Market
23. France High Energy Cyclotron Market
24. Italy High Energy Cyclotron Market
25. Spain High Energy Cyclotron Market
26. Eastern Europe High Energy Cyclotron Market
27. Russia High Energy Cyclotron Market
28. North America High Energy Cyclotron Market
29. USA High Energy Cyclotron Market
30. Canada High Energy Cyclotron Market
31. South America High Energy Cyclotron Market
32. Brazil High Energy Cyclotron Market
33. Middle East High Energy Cyclotron Market
34. Africa High Energy Cyclotron Market
36. High Energy Cyclotron Market Competitive Landscape And Company Profiles
37. High Energy Cyclotron Market Other Major And Innovative Companies
41. High Energy Cyclotron Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
High Energy Cyclotron Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses high energy cyclotron market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for high energy cyclotron? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high energy cyclotron market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Single Particle Cyclotron; Multi Particle Cyclotron2) By Technology: Electromagnetic Systems; Radio Frequency Systems; Vacuum Systems; Beam Extraction Systems; Cooling Systems
3) By Energy Level: Above 70 Mega Electron Volts; 30-70 Mega Electron Volts; Below 30 Mega Electron Volts
4) By Application: Oncology; Cardiology; Neurology; Other Applications
5) By End Use: Hospitals; Research Institutions; Diagnostic Centers
Subsegments:
1) By Single Particle Cyclotron: Proton Accelerating Cyclotron; Electron Accelerating Cyclotron; Deuteron Accelerating Cyclotron; Heavy Ion Single Beam Cyclotron2) By Multi Particle Cyclotron: Dual Particle Beam Cyclotron; Multi Ion Acceleration Cyclotron; Simultaneous Multi Beam Cyclotron; Variable Particle Type Cyclotron
Companies Mentioned: Hitachi Ltd.; Siemens Healthineers AG (including Varian Medical Systems); GE HealthCare Technologies Inc.; Thales Group; L3Harris Technologies; Sumitomo Heavy Industries Ltd.; Ion Beam Applications SA (IBA); The Japan Steel Works Ltd. (JSW); TeamBest Global Companies (Best Cyclotron Systems); Mevion Medical Systems Inc.; Avelion (ALCEN Group); Sichuan Longevous Beamtech Co. Ltd.; Hefei CAS Ion Medical and Technical Devices Co. Ltd. (CIM); Danfysik A/S; Haiming Medical Technology; Advanced Cyclotron Systems Inc. (ACSI)
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Hitachi Ltd.
- Siemens Healthineers AG (including Varian Medical Systems)
- GE HealthCare Technologies Inc.
- Thales Group
- L3Harris Technologies
- Sumitomo Heavy Industries Ltd.
- Ion Beam Applications SA (IBA)
- The Japan Steel Works Ltd. (JSW)
- TeamBest Global Companies (Best Cyclotron Systems)
- Mevion Medical Systems Inc.
- Avelion (ALCEN Group)
- Sichuan Longevous Beamtech Co. Ltd.
- Hefei CAS Ion Medical and Technical Devices Co. Ltd. (CIM)
- Danfysik A/S
- Haiming Medical Technology
- Advanced Cyclotron Systems Inc. (ACSI)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.17 Billion |
| Forecasted Market Value ( USD | $ 1.63 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
